Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Jacques Bruijn
Medium-Dose Riboflavin as a Prophylactic Agent in Children With Migraine: A Preliminary Placebo-Controlled, Randomised, Double-Blind, Cross-Over Trial
Cephalalgia
Medicine
Neurology
Related publications
CCR5 Blockade in Rheumatoid Arthritis: A Randomised, Double-Blind, Placebo-Controlled Clinical Trial
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Randomised, Double-Blind, Placebo-Controlled Trial of EPs 7630 in Adults With COPD
Respiratory Medicine
Pulmonary
Respiratory Medicine
Rizatriptan vs. Ibuprofen in Migraine: A Randomised Placebo-Controlled Trial
Journal of Headache and Pain
Medicine
Neurology
Anesthesiology
Pain Medicine
Prophylactic Antidepressant Treatment in Patients With Hepatitis C on Antiviral Therapy: A Double-Blind, Placebo-Controlled Trial
Psychosomatics
Psychiatry
Arts
Applied Psychology
Mental Health
Humanities
A Human Trigeminovascular Biomarker for Antimigraine Drugs: A Randomised, Double-Blind, Placebo-Controlled, Crossover Trial With Sumatriptan
Cephalalgia
Medicine
Neurology
Antioxidant Supplementation for the Prevention of Kwashiorkor in Malawian Children: Randomised, Double Blind, Placebo Controlled Trial
BMJ
Limited Effect of Sulphasalazine Treatment in Reactive Arthritis. A Randomised Double Blind Placebo Controlled Trial
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Photodynamic Therapy for Dysplastic Barrett's Oesophagus: A Prospective, Double Blind, Randomised, Placebo Controlled Trial
Gut
Gastroenterology
Chondroitin Sulfate Plus Glucosamine Sulfate Does Not Show Superiority Over Placebo in a Randomised, Double Blind, Placebo-Controlled Clinical Trial in Patients With Knee Osteoarthritis
Osteoarthritis and Cartilage
Sports Medicine
Rheumatology
Orthopedics
Biomedical Engineering